亚群合作导致肝胆肿瘤类器官产生耐药性。
Subpopulation cooperation renders drug resistance of hepatobiliary tumor organoids.
作者信息
Qi Kuo, Liu Rong
机构信息
The First Clinical Medical College, Inner Mongolia Medical University, Hohhot 010110, China.
Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China.
出版信息
Chin J Cancer Res. 2022 Aug 30;34(4):422-424. doi: 10.21147/j.issn.1000-9604.2022.04.10.
Abstract
Hepatobiliary tumors are of high grade of heterogeneity, which is recognized as a key contributor to drug resistance and poor disease prognosis. However, the intrinsic mechanism between heterogeneity and drug response in hepatobiliary tumor is still largely unknown. Using tumor organoid models, Wang and her colleagues have found that cooperation among distinct subpopulations might be a key mechanism for drug resistance in hepatobiliary tumor.
摘要
肝胆肿瘤具有高度的异质性，这被认为是耐药性和疾病预后不良的关键因素。然而，肝胆肿瘤异质性与药物反应之间的内在机制仍 largely unknown。利用肿瘤类器官模型，王和她的同事们发现不同亚群之间的合作可能是肝胆肿瘤耐药的关键机制。
相似文献
1
Subpopulation cooperation renders drug resistance of hepatobiliary tumor organoids.亚群合作导致肝胆肿瘤类器官产生耐药性。
Chin J Cancer Res. 2022 Aug 30;34(4):422-424. doi: 10.21147/j.issn.1000-9604.2022.04.10.
2
Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?肝胆类器官及其在肝脏健康和疾病研究中的应用：我们做到了吗？
Hepatology. 2021 Oct;74(4):2251-2263. doi: 10.1002/hep.31772. Epub 2021 May 28.
3
Generation of hepatobiliary organoids from human induced pluripotent stem cells.从人诱导多能干细胞生成肝胆类器官。
J Hepatol. 2019 Jun;70(6):1145-1158. doi: 10.1016/j.jhep.2018.12.028. Epub 2019 Jan 7.
4
Hepatobiliary tumor organoids for personalized medicine: a multicenter view on establishment, limitations, and future directions.用于个性化医疗的肝胆肿瘤类器官：关于建立、局限性及未来方向的多中心观点
Cancer Cell. 2022 Mar 14;40(3):226-230. doi: 10.1016/j.ccell.2022.02.001. Epub 2022 Feb 10.
5
Liver sinusoidal endothelial cells promote the differentiation and survival of mouse vascularised hepatobiliary organoids.肝窦内皮细胞促进小鼠血管化肝胆类器官的分化和存活。
Biomaterials. 2020 Aug;251:120091. doi: 10.1016/j.biomaterials.2020.120091. Epub 2020 May 5.
6
Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.阑尾癌患者特定肿瘤类器官模型预测治疗前化疗疗效：一项可行性研究。
Ann Surg Oncol. 2019 Jan;26(1):139-147. doi: 10.1245/s10434-018-7008-2. Epub 2018 Nov 9.
7
Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology.利用类器官技术研究结直肠癌中的细胞异质性和药物敏感性。
Curr Opin Genet Dev. 2018 Oct;52:117-122. doi: 10.1016/j.gde.2018.09.001. Epub 2018 Sep 24.
8
Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma.肿瘤微环境在患者来源的类器官模型中的整合有助于定义肾细胞癌的精准医学。
Front Immunol. 2022 May 3;13:902060. doi: 10.3389/fimmu.2022.902060. eCollection 2022.
9
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review.肿瘤生物学和药物测试中患者来源的膀胱癌类器官模型：一项系统综述
Cancers (Basel). 2022 Apr 20;14(9):2062. doi: 10.3390/cancers14092062.
10
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.从肿瘤活检针获得的人类肝癌类器官模型。
Cell Rep. 2018 Jul 31;24(5):1363-1376. doi: 10.1016/j.celrep.2018.07.001.
引用本文的文献
1
CellPhoneDB v5: inferring cell-cell communication from single-cell multiomics data.CellPhoneDB v5：从单细胞多组学数据推断细胞间通讯
Nat Protoc. 2025 Mar 25. doi: 10.1038/s41596-024-01137-1.
本文引用的文献
1
Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids.单细胞转录组分析揭示肝胆肿瘤类器官中肿瘤内异质性和耐药的潜在机制。
Adv Sci (Weinh). 2021 Jun;8(11):e2003897. doi: 10.1002/advs.202003897. Epub 2021 Mar 23.
2
NEAT1 is Required for the Expression of the Liver Cancer Stem Cell Marker CD44.NEAT1 对于肝癌干细胞标志物 CD44 的表达是必需的。
Int J Mol Sci. 2020 Mar 11;21(6):1927. doi: 10.3390/ijms21061927.
3
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.患者来源的类器官模型可模拟转移性胃肠道癌症的治疗反应。
Science. 2018 Feb 23;359(6378):920-926. doi: 10.1126/science.aao2774.
4
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.上皮-间质转化、癌症干细胞与耐药性：机制联系及临床意义
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629. doi: 10.1038/nrclinonc.2017.44. Epub 2017 Apr 11.
5
Intra-tumor heterogeneity from a cancer stem cell perspective.从癌症干细胞角度看肿瘤内异质性。
Mol Cancer. 2017 Feb 16;16(1):41. doi: 10.1186/s12943-017-0600-4.
Zotero 插件